Capital Fund Management (CFM)
TDOC icon

Capital Fund Management (CFM)’s Teladoc Health TDOC Stock Holding History

Capital Fund Management (CFM)’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-54,000
Closed -$470K – 2679
2025
Q2 		$470K Buy
54,000
+25,600
+90% +$186K ﹤0.01% 2202
2025
Q1 		$226K Sell
28,400
-69,600
-71% -$704K ﹤0.01% 1931
2024
Q4 		$891K Sell
98,000
-58,200
-37% -$562K ﹤0.01% 1786
2024
Q3 		$1.43M Sell
156,200
-516,900
-77% -$4.28M ﹤0.01% 1581
2024
Q2 		$6.58M Buy
673,100
+619,600
+1,158% +$7.56M 0.02% 841
2024
Q1 		$808K Sell
53,500
-42,300
-44% -$768K ﹤0.01% 1771
2023
Q4 		$2.06M Sell
95,800
-400
-0.4% -$7.38K 0.01% 1517
2023
Q3 		$1.79M Sell
96,200
-415,600
-81% -$9.7M 0.01% 1411
2023
Q2 		$13M Buy
511,800
+309,500
+153% +$7.79M 0.05% 472
2023
Q1 		$5.24M Buy
202,300
+48,800
+32% +$1.31M 0.03% 724
2022
Q4 		$3.63M Sell
153,500
-72,500
-32% -$1.95M 0.02% 737
2022
Q3 		$5.73M Sell
226,000
-286,700
-56% -$10.1M 0.05% 503
2022
Q2 		$17M Sell
512,700
-81,400
-14% -$3.46M 0.15% 168
2022
Q1 		$42.9M Sell
594,100
-47,600
-7% -$3.43M 0.35% 46
2021
Q4 		$58.9M Sell
641,700
-187,900
-23% -$22.5M 0.42% 23
2021
Q3 		$105M Buy
829,600
+471,300
+132% +$68.6M 0.78% 8
2021
Q2 		$59.6M Buy
358,300
+328,500
+1,102% +$53.2M 0.47% 31
2021
Q1 		$5.42M Buy
+29,800
New +$6.91M 0.06% 391
2020
Q4 		– Sell
-15,000
Closed -$3.29M – 1552
2020
Q3 		$3.29M Sell
15,000
-6,300
-30% -$1.33M 0.04% 483
2020
Q2 		$4.06M Buy
+21,300
New +$3.73M 0.06% 338
2019
Q2 		– Sell
-6,300
Closed -$350K – 1908
2019
Q1 		$350K Sell
6,300
-29,100
-82% -$1.78M ﹤0.01% 1393
2018
Q4 		$1.75M Buy
35,400
+16,900
+91% +$1.03M 0.02% 895
2018
Q3 		$1.6M Buy
18,500
+9,300
+101% +$663K 0.01% 1208
2018
Q2 		$534K Buy
+9,200
New +$449K ﹤0.01% 1570

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital Fund Management (CFM)'s TDOC Position: Q1 2025 in Review

Capital Fund Management (CFM) sold out of Teladoc Health (TDOC) in Q1 2025, closing a stake of 241,705 shares — an estimated $2.45M sold.

Capital Fund Management (CFM) first reported a position in TDOC in Q4 2018 and held it in 13 quarters. The position peaked at $10.3M in Q4 2020. 383 funds tracked by Wall St. Rank hold TDOC as of Q1 2025.

  • Capital Fund Management (CFM) reported no remaining Teladoc Health position as of Q1 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 241,705 Teladoc Health shares in Q1 2025, an estimated $2.45M.
  • Capital Fund Management (CFM) first reported a position in Teladoc Health in Q4 2018 and held it in 13 quarters.
  • Capital Fund Management (CFM)'s Teladoc Health position peaked at $10.3M in Q4 2020.
  • 383 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2025, filed 14 May 2025.